8:30 Registration. Opening Address from Chairman Mingde Xia, Senior Director of New Ventures, Johnson & Johnson Innovation

Size: px
Start display at page:

Download "8:30 Registration. Opening Address from Chairman Mingde Xia, Senior Director of New Ventures, Johnson & Johnson Innovation"

Transcription

1

2 AGENDA at A GLANCE DAY ONE DAY TWO 8:30 Registration 11:00 Registration 9:00 Conference 10:50 Speed Networking Tea break 11:20 Conference meetings 14:00 Conference 12:00 Luncheon 15:10 Speed Networking 13:20 Company Presentations 15:20 Tea break 14:00 Match Making Conference 15:50 Conference 15: meetings 17:30 Closing remarks 16:00 The End Exhibition Exhibition AGENDA DAY 1 Thursday 22 Jan :00 Registration & Exhibition Open 14:00 14:10 Opening Address from Chairman Mingde Xia, Senior Director of New Ventures, Johnson & Johnson Innovation 14:10 14:40 Opening Keynote: Biopharma Innovation and its Impact on Patients A Leading biopharma executive will talk about how changes in the overall healthcare market are affecting the corporate strategies in addressing diseases, such as patient access, partnering deals. This opening session will help you better understand the most significant factors influencing innovations in vaccines and biosimilars manufacturing and the business of fulfilling medical needs, and well as how to propel their development and production. Dr. Willard H. Dere, Senior Vice President, Global Development and Chief Medical Officer, Amgen 14:40 15:10 15:10 15:20 15:20 15:50 15:50 16:20 16:20 16:50 REGULATORY UPDATE with Q&A Current Status of Chinese biotechnical Development & Policies Bing Zeng, Deputy General Manager, Sinopharm Group Speed Name card Exchanging Please prepare your name cards and get ready to network with 200+ industrial peers! Tea break & Networking Visit the exhibition area and be marveled by the latest industry solutions and technologies that can help advance your R&D and manufacturing capabilities How to Integrate with International Biopharmaceutical Market Dr. Ming Xu, Vice President, China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE) EU Regulations & Management of Biopharmaceuticals Senior Representative, UK Medicines and Healthcare Products Regulatory Agency (TBC) 16:50 17:20 Multinational Enterprises Strategy on Biopharm Development & Technology Cooperation Pfizer (TBC) 17:20 17:30 Day One Questions & Answers 17:30 17:35 Day One Closing Remarks from Chairman

3 AGENDA DAY 2 Friday 23 Jan :30 Registration & Exhibition Open 9:00 9:10 Address from Chairman International Technology Transfer with Match Making Denmark Technology Transfer Project A, B, C 9:10 9:30 Organizer: Invest in Denmark Pharmaceutical sector is the largest exporting industry in Denmark. Danish companies such as Novo Nordisk, Lunbeck, Leo are particularly outstanding in Insulin, CNS, skin care and vaccine areas. The Medicon 9:30 9:50 Valley located in the North of Denmark is one of the three biomedical clusters in Europe, attracting more and more investment from China in recent years. UK 9:50 10:10 Technology Transfer Project D Organizer: 10:10 10:30 UK Trade & Investment (UKTI) Israel 10:30 10:50 Technology Transfer Project E 10:50 11:20 11:20 11:40 11:40 12:00 Strategic Innovative PARTNERING Panel Discussion Engage China Vaccine Stakeholders for WHO Vaccine Prequalification and GAVI Markets What are the biggest challenges facing China in the pursuit of WHO prequalification and global public market: such as human resources, price competition, distribution management, quality, regulatory or insurance, etc.? Why is China so behind India in terms of WHO vaccine prequalification and global supply? Has the Chinese government take or will take some serious initiatives to tackle the awkward situation? This session will discuss how to speed up from different angles the process of China s participation in WHO prequalification and GAVI markets, including obstacles encountered, lessons learned, experiences sharing and recommendations. Moderator: Jack Zhang, China Representative, PATH Panelists from, (TBC) CNBG WHO Representative in China Hualan BMGF Beijing Office GAVI Organizer: IsCham Beijing Speed Networking & Tea break Senior executives from leading pharmaceutical companies will be invited to join this Speed Networking session, and you are welcome to talk with them one by one face to face. Israel Technology Transfer Project F Organizer: IsCham Beijing Cuba Technology Transfer Project G 12:00 13:20 Luncheon and Networking 13:20 14:00 14:00 15:00 15:00 16:00 Technology Transfer Project Match Making Project A, B, C, D, E, F, G 16:00 The End of the Conference Panel Discussion Driving Strategic Innovative Partnering to Overcome R&D Challenges in China Moderator: Dr. Mingde Xia, Senior Director of New Ventures, Johnson & Johnson Innovation Panelists: Dr. Yi YANG, Director of Preclinical Safety, Sanofi (China) Dr. Ke Wu,CEO,Shanghai BravoBio Co., Ltd. Dr. Li Shi,CEO, Shanghai Zerun Biotech Co., Ltd Dr. Xiaoming Zou, Chief Business Officer, Eddingpharm Co. Ltd(TBC) Company Presentations (20 minutes/presentation, Room A, B, C, D, E) Benefits of Presenting: Increase your visibility and attract more partners Pitch your company s story, pipeline, and objectives to a global audience Be heard by business development executives, investors, research analysts, and the media Potential partners will recognize you, resulting in more business opportunities Invite target audiences to your presentation Panel Discussion Enhancing Collaborations between Pharma and Investors on Expanding R&D Budgets Pharma company R&D budgets have been under pressure in recent years, struggling to find ways to keeping advanced in attractive drug candidates from their own pipelines while simultaneously looking outside for good programs they can acquire. At the same time, the investor landscape has changed and there are more new opportunities than ever before to attract capital. This session will identify how pharma companies partner with investors to develop drugs and generate investment returns, and provide an insight on practical and tactical methods to raise capital. Panelists: Che Yan, CSO, Bayer China Maykin Ho,Advisory Director,Goldman Sachs (Asia) LLC Forest Xu,Partner,WI Harper Group Helen Chen, Director and Partner, L.E.K. Consulting(TBC) Private Meetings Plan face to face meetings with fellow industry peers and client prospects you wish to meet and network with Private Meetings

4

5

6

7

8 BioLink 2015 Delegate Registration Form Jan Beijing Yizhuang Biomedical Park Please complete, sign and return to: China Chamber of Commerce for Import & Export of Medicines & Health Products Attn: Ms. Sharon Wu Tel:(8610) COMPANY INFORMATION Company Name: Address: Postal Code: Website: 2. COMPANY REPRESENTATIVE(S) Contact Person Job Title Tel E Mail Fax 1. Mr/ Ms* 2. Mr/ Ms* 3. Mr/ Ms* 3. PARTICIPATION FEE Please select Participation Fee No. of Company Representatives Total Amount Pay in USD ** Aug. 30 Nov.30 USD 98 per delegate Dec.1 Jan 21 USD 198 per delegate Jan 22 Jan 23 USD 298 per delegate (Full payment and non refundable ) The participation fees include event documentation, tea break, lunch and on site services. 4. PAYMENT INSTRUCTIONS: 1. Please instruct bank to include company name, name(s) of participant(s) and BioLink 2015 on remittance advice, and advise us by the scanning to wuyushuang@cccmhpie.org.cn of your remittance receipt. 2. All bank charges should be borne by the participants. 3. FOR PAYMENT IN USD: Must fulfill the completed company names! Payment made by bank transfer to Company Name: SHANGHAI UBM SINOEXPO INT'L EXHIBITION CO., LTD. Bank Name: CHINA MERCHANTS BANK SHANGHAI BRANCH HUAIHAI SUB BRANCH A/C NO: BANK ADDRESS: 1155 HUAIHAI ROAD(M, SHANGHAI , P.R.CHINA) Swift code: CMBCCNBS051 COMPANYADDRESS: 8/F XIANDAI MANSION, 218 XIANGYANG ROAD(S), SHANGHAI , CHINA 5. Others A. The participation company should make sure all the submitted information is correct and accurate. This registration form shall be effective upon the signing and stamp. B. The participation company should pay all amounts within 7 working days once the registration form is effective upon the signing and stamp. The seats will only be reserved for the delegates who paid full amount before the conference. C. 3+ Attendees, 10% Discount; 5+ Attendees, 20% Discount. D. The conference organization reserves all rights for final explanation,including the changing of agenda and speakers due to force majeure. Company: Signature: Stamp: Date: USD 主办方 : 中国医药保健品进出口商会上海博华国际展览有限公司北京亦庄生物医药园